Promoting domestic medicine: FDA, MSF discuss drug quality and production

KABUL (Agencies): Dr. Abdul Bari Omar, the Acting Head of the National Food and Drug Administration, recently held a meeting with representatives from Doctors Without Borders (MSF). The focus of their discussion was the quality and use of drugs produced within Afghanistan. Dr. Omar emphasized the importance of healthcare institutes, including MSF, using domestically produced medicine. The meeting also covered the import of foreign medicine to Afghanistan and addressed challenges and suggestions put forth by MSF. Filipe Ribeiro, the representative of MSF in Afghanistan, acknowledged the importance of using Afghan-produced drugs and committed to discussing this issue with other officials within the organization. It’s worth noting that several drug production companies have been established in Afghanistan in recent years. These companies operate in accordance with international standards, demonstrating the potential for high-quality domestic drug production.